PPARG protective_against Alzheimer’s disease
Evidence from:
primary |
all sources
Evidence (2 sources)
prolonged treatment with PPARγ agonists can reduce Alzheimer’s disease pathology
confidence: 0.92
PPARγ activation ... may be a promising therapy for Alzheimer’s disease
confidence: 0.70